3-way comparison
Saxenda vs Rybelsus vs Wegovy
Side-by-side breakdown — efficacy, cost, regulatory status, и who each option fits best.
Side-by-side comparison
| Attribute | Saxenda | Rybelsus | Wegovy |
|---|---|---|---|
| Generic name | liraglutide | semaglutide | semaglutide |
| Drug class | GLP-1 Agonists | GLP-1 Agonists | GLP-1 Agonists |
| Regulatory status | FDA approved | FDA approved | FDA approved |
| Manufacturer | Novo Nordisk | Novo Nordisk | Novo Nordisk |
| Avg retail price | $1349/mo | $968/mo | $1349/mo |
| Without insurance | $1100–$1500/mo | $850–$1100/mo | $1349–$1500/mo |
| Savings card max | $25/mo | $10/mo | — |
| Shortage status | not_listed | not_listed | resolved |
FAQ
What is the difference between Saxenda, Rybelsus, and Wegovy?
Saxenda (liraglutide), Rybelsus (semaglutide), and Wegovy (semaglutide) are GLP-1 medications used для weight management или type 2 diabetes. Key differences: Saxenda is FDA-approved, Rybelsus is FDA-approved, Wegovy is FDA-approved.
Which is most effective for weight loss: Saxenda, Rybelsus, or Wegovy?
Effectiveness varies by individual. In clinical trials, tirzepatide-based drugs (Mounjaro, Zepbound) produced ~22% average body-weight loss vs ~15% for semaglutide-based (Ozempic, Wegovy). Discuss с your prescriber.
Which is cheapest?
Cash retail price: Rybelsus $968/mo · Saxenda $1349/mo · Wegovy $1349/mo. Compounded versions через telehealth typically run 60-80% less.
See per-drug deep dives: Saxenda review · Rybelsus review · Wegovy review
2-way head-to-heads
Drill down into any pair от the three above для deeper side-by-side analysis.
Already on one? Switching guides
Dose conversion + transition timeline для each directional switch.